These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5508902)

  • 21. [Pharmacokinetics of dimeylaminophenazone, 4-aminophenazone and phenazone in rats of various ages].
    Klinger W
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):309-22. PubMed ID: 5348404
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of theophylline in patients with liver diseases.
    Staib AH; Schuppan D; Lissner R; Zilly W; von Bomhard G; Richter E
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):500-2. PubMed ID: 7203726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal aminopyrine metabolism in patients with chronic hepatitis.
    Hepner GW; Piken E; Lechago J
    West J Med; 1981 May; 134(5):390-3. PubMed ID: 7257348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the excretory liver function using 24- 14 C-cholic acid].
    Klapdor R
    Acta Hepatogastroenterol (Stuttg); 1972 Feb; 19(1):53-66. PubMed ID: 4664356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in aminophenazone metabolism with acute hepatitis in children (author's transl)].
    Windorfer A; Müller G; Stehr C
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1460-4. PubMed ID: 913279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alcohol catabolism in liver diseases].
    Lelbach WK
    Dtsch Med Wochenschr; 1969 May; 94(21):1136-7. PubMed ID: 5769159
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 28. [Phenazon metabolism in children with liver diseases].
    Orzechowska-Juzwenko K; Rabenda C; Wiela-Hojeńska A; Kubicz Z; Saraczyńska E; Rudkowski Z; Drabik E
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):265-7. PubMed ID: 1437728
    [No Abstract]   [Full Text] [Related]  

  • 29. [Aminophenazone metabolism in chronic insufficiency of the right heart].
    Wagner K; Koppatz K
    Z Gesamte Inn Med; 1971 Nov; 26(21):Suppl:298-300. PubMed ID: 5149921
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Liver diseases and changes in the locomotor system].
    Zulkarneev RA
    Ortop Travmatol Protez; 1991 Jul; (7):75-8. PubMed ID: 1762751
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of isradipine in patients with chronic liver disease.
    Cotting J; Reichen J; Kutz K; Laplanche R; Nüesch E
    Eur J Clin Pharmacol; 1990; 38(6):599-603. PubMed ID: 2142648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factors stimulating liver regeneration; role of anabolic steroids in reactive regeneration in chronic liver diseases].
    Nicolaescu T; Bordeianu A; Bittman E; Gabrielescu E; Stoiculescu P; Drăgulescu N
    Rev Roum Physiol; 1969; 6(2):119-26. PubMed ID: 5821595
    [No Abstract]   [Full Text] [Related]  

  • 36. [Disorders of carbohydrate metabolism in chronic hepatitis and cirrhosis of the liver (author's transl)].
    Danko M; Spanár E; Holan J; Záhradný V; Kurocka J
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):173-7. PubMed ID: 4447982
    [No Abstract]   [Full Text] [Related]  

  • 37. [The diagnostic relevance of the aminopyrine breath test in liver disease].
    Wildgrube HJ; Stang H
    Z Gastroenterol; 1982 Nov; 20(11):667-72. PubMed ID: 7180067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peculiarities of histamine metabolism in chronic hepatitis and liver cirrhosis].
    Shastin NN
    Klin Med (Mosk); 1972 Jul; 50(7):39-42. PubMed ID: 5052639
    [No Abstract]   [Full Text] [Related]  

  • 39. [Case-control study of hepatitis C HBs Ag and antivirus antibodies in chronic hepatopathies].
    Maiga MY; Dembele M; Maiga I; Sanago B; Sangare D; Traoré HA
    Sante; 2002; 12(4):389-92. PubMed ID: 12626293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of ICG and BSP elimination through the liver at different dosages].
    Jaross W; Schentke KU; Richter B; Tschöpel L; Renger F
    Z Gesamte Inn Med; 1970 Sep; 25(18):834-40. PubMed ID: 5522140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.